Tuberculosis
Studies from St. Louis University yield new information about tuberculosis
Published in TB and Outbreaks Week, December 9th, 2008
According to a study from the United States, "One strategy for improving anti-tuberculosis (TB) vaccination involves the use of recombinant bacille Calmette-Guerin (rBCG) overexpressing protective TB antigens. rBCG30, which overexpresses the Mycobacterium tuberculosis secreted antigen Ag85b, was the first rBCG shown to induce significantly greater protection against TB in animals than parental BCG. We report here the first double-blind phase 1 trial of rBCG30 in 35 adults randomized to receive either rBCG30 or parental Tice BCG intradermally."
"Clinical reactogenicity was assessed, and state-of-the-art immunological assays were used to study Ag85b-specific immune...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- HIV/AIDS Co-Infection
Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies - Apoptosis
Research from University of Porto, Medical Department broadens understanding of apoptosis - Arthritis
Reports on arthritis findings from University of Maryland provide new insights - Atrial Fibrillation
Study results from O.E. Johansen et al provide new insights into atrial fibrillation - Bird Flu
New data from M.A. Hofmann et al illuminate research in bird flu - Bird Flu
New findings reported from Erasmus University describe advances in bird flu - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
